Factors associated with concordant estrogen receptor expression at diagnosis and centralized re-assay in a Danish population-based breast cancer study (Q35690804)

From Wikidata

Jump to navigation Jump to search

scientific article published on 30 November 2011

Language	Label	Description	Also known as
English	Factors associated with concordant estrogen receptor expression at diagnosis and centralized re-assay in a Danish population-based breast cancer study	scientific article published on 30 November 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Factors associated with concordant estrogen receptor expression at diagnosis and centralized re-assay in a Danish population-based breast cancer study (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Stephen Hamilton-Dutoit

10

object named as

Stephen Hamilton-Dutoit

0 references

Henrik Toft Sørensen

8

object named as

Henrik Toft Sørensen

0 references

object named as

Thomas P Ahern

4

0 references

Rebecca A Silliman

object named as

Rebecca A Silliman

7

0 references

9

object named as

Timothy L Lash

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

author name string

Deirdre P Cronin-Fenton

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Ylva Hellberg

2

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Kristina L Lauridsen

3

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Jens Peter Garne

5

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Carol Rosenberg

6

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

publication date

30 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Acta Oncologica

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

254-261

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

CYP2D6 inhibition and breast cancer recurrence in a population-based study in Denmark

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3264781

27 July 2018

Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3264781

27 July 2018

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3264781

27 July 2018

Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3264781

27 July 2018

Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3264781

27 July 2018

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3264781

27 July 2018

Comparison of estrogen receptor results from pathology reports with results from central laboratory testing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3264781

27 July 2018

Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3264781

27 July 2018

Epidemiology. When an entire country is a cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3264781

27 July 2018

Paraffin section immunocytochemistry and cytosol-based ligand-binding assays for ER and PR detection in breast cancer: the time has come for more objectivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3264781

27 July 2018

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3264781

27 July 2018

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3264781

27 July 2018

Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3264781

27 July 2018

Determination of estrogen receptors in paraffin-embedded tissue. Techniques and the value in breast cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3264781

27 July 2018

Tamoxifen: catalyst for the change to targeted therapy

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.633556

21 January 2018

The prognostic value of immunohistochemical estrogen receptor analysis in paraffin-embedded and frozen sections versus that of steroid-binding assays

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.633556

21 January 2018

Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.633556

21 January 2018

Estrogen Receptor analyses in the Danish Breast Cancer Cooperative Group. History, methods, prognosis and clinical implications.

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.633556

21 January 2018

The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.633556

21 January 2018

Delay to formalin fixation effect on breast biomarkers

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.633556

21 January 2018

Trends in breast-conserving surgery in Denmark, 1982-2002.

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.633556

21 January 2018

Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.633556

21 January 2018

Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases.

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.633556

21 January 2018

Relationship between radioligand binding assay, immunoenzyme assay and immunohistochemical assay for estrogen receptors in human breast cancer and association with tumor differentiation

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.633556

21 January 2018

Comparison of immunohistochemical and biochemical measurement of steroid receptors in primary breast cancer: evaluation of discordant findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/22129357

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen

1 reference

https://pubmed.ncbi.nlm.nih.gov/22129357

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Sp gamma in frozen sections or cytosol-based ligand-binding assays

1 reference

https://pubmed.ncbi.nlm.nih.gov/22129357

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of Standardized Immunohistochemical and Biochemical Assays for Estrogen and Progesterone Receptors in Breast Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22129357

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3109/0284186X.2011.633556

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35690804&oldid=1962329193"